deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteï¾’s Janelia Research Campus announced that they had…
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaï¾® (apremilast), the only oral, non-biologic treatment for psoriasis…
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ï¾ leaseï¾ …
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
On Jul. 24, 2019, the Oregon Health Science University (OHSU) Transplant Program – one of the oldest, largest…
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
On Jul. 3, 2019, Evotec announced the strategic transaction to acquire Just Biotherapeutics, signed May 20, 2019, had…
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…
On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
On Jun. 10, 2019, Genentech drug Polivy (polatuzumab vedotin-piiq) announced the U.S. Food and Drug Administration (FDA) had…
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…